Nasal Steroids in Controlled Glaucoma

Summary

Patients that have consented to participate in the study will be randomly assigned to one of two groups: control group or nasal steroid group. Patients in the control group will receive normal saline inhaler. Patients in the study group will receive steroid inhaler Follow-up visits are: baseline and weeks 2, 4, 6 after starting the spray. Intraocular pressure will be recorded on all visits.

Timeline

Start

2010-01

Primary completion

2010-07

Completion

2010-07

Drugs

Indications